Pfizer nabs FDA approval for Humira biosim

Abrilada is the fifth Humira biosimilar approved in the U.S. and will join generics from Mylan, Samsung Bioepis and Sandoz when AbbVie ' s blockbuster has its patent expire in 2023.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news